Diversify Advisory Services’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,491
Closed -$277K – 1351
2026
Q2
$277K Buy
+5,491
New +$282K ﹤0.01% 1083
2026
Q1
– Sell
-6,559
Closed -$427K – 661
2025
Q4
$427K Buy
6,559
+722
+12% +$44.2K 0.01% 654
2025
Q3
$354K Buy
5,837
+256
+5% +$17.8K 0.01% 666
2025
Q2
$364K Buy
5,581
+1,217
+28% +$102K 0.01% 634
2025
Q1
$358K Buy
4,364
+1,004
+30% +$82.4K 0.02% 441
2024
Q4
$249K Sell
3,360
-127
-4% -$9.9K 0.01% 534
2024
Q3
$250K Buy
3,487
+69
+2% +$4.89K 0.01% 547
2024
Q2
$233K Sell
3,418
-2,433
-42% -$165K 0.01% 569
2024
Q1
$419K Buy
+5,851
New +$391K 0.02% 462

Other funds holding PBH

Diversify Advisory Services's PBH Position: Q3 2026 in Review

Diversify Advisory Services sold out of Prestige Consumer Healthcare (PBH) in Q3 2026, closing a stake of 5,491 shares — an estimated $277K sold.

Diversify Advisory Services first reported a position in PBH in Q1 2024 and held it in 9 quarters. The position peaked at $427K in Q4 2025. 33 funds tracked by Wall St. Rank hold PBH as of Q3 2026.

  • Diversify Advisory Services reported no remaining Prestige Consumer Healthcare position as of Q3 2026 after selling out during the quarter.
  • Diversify Advisory Services sold 5,491 Prestige Consumer Healthcare shares in Q3 2026, an estimated $277K.
  • Diversify Advisory Services first reported a position in Prestige Consumer Healthcare in Q1 2024 and held it in 9 quarters.
  • Diversify Advisory Services's Prestige Consumer Healthcare position peaked at $427K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2026.

Based on Diversify Advisory Services's 13F filing for Q3 2026, filed 20 Oct 2026.